Asymmetrisches Dimethylarginin

  • A. M. GressnerEmail author
  • O. A. Gressner
Part of the Springer Reference Medizin book series (SRM)


  1. McCarty MF (2016) Asymmetric dimethylarginine is a well established mediating risk factor for cardiovascular morbidity and mortality-should patients with elevated levels be supplemented with citrulline? Healthcare (Basel) 4(3):pii,E40Google Scholar
  2. Schwedhelm E, Böger RH (2011) The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol 5:275–285CrossRefGoogle Scholar
  3. Sitar ME (2016) Asymmetric dimethylarginine and its relation as a biomarker in nephrologic diseases. Biomarker Insights 11:131–137PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Labor Dr. Wisplinghoff BerlinBerlinDeutschland
  2. 2.Labor Dr.Wisplinghoff KölnKölnDeutschland

Personalised recommendations